Before You Apply: Lenskart & Studds IPO Compared (GMP, Valuation, Risks)

1) Quick Snapshot (as of Nov 2, 2025, IST)

• Issue size
  
• Lenskart Solutions: ~₹7,278 crore (Fresh ₹2,150 cr + OFS ~12.76 crore shares) at ₹382–₹402. Bids: Oct 31–Nov 4; tentative listing Nov 10.  
• Studds Accessories: ~₹455.49 crore, 100% OFS, price band ₹557–₹585. Bids: Oct 30–Nov 3.  
• 
  
• Grey Market Premium (GMP) & implied listing pop
  
• Lenskart: GMP about ₹84 → implied ~21% premium vs ₹402 (indicative price ≈ ₹486). (GMP recently eased from ₹95/₹108).  
• Studds: GMP about ₹63–₹67 → implied ~10–11.5% premium vs ₹585 (indicative price ≈ ₹648–₹652).  
• 
  
• Subscription pulse (early days)
  
• Lenskart: Fully subscribed on Day 1; QIB, retail traction visible.  
• Studds: Day-2 overall ~5x bids in Mint’s running coverage; day-1 early bids ~20% (ET) and 1.54x by end-day in another update.  
• 
  

2) What each business does (name, model, scale)

A) Lenskart Solutions Ltd (Eyewear, omni-channel)

• Integrated model—design, manufacture, brand, retail eyewear; large store network in India plus overseas.  
• Seeks valuation ~₹69,500–70,000 crore (~US$7.9B) at upper band; last private valuation ~US$6.1B (Sep 2025).  
• Use of proceeds: Fresh issue ₹2,150 cr for growth (details per RHP/notes). OFS by founders/financial investors including SoftBank, Temasek, Kedaara.  

B) Studds Accessories Ltd (Two-wheeler helmets & riding gear)

• India’s leading helmet brand(s) Studds and SMK; product lines include helmets, jackets, gloves, luggage, rainwear. Sales mix spans distributors, OEMs, D2C.  
• 100% OFS—no fresh capital to company; promoters and other holders selling.  

3) Key numbers that matter (price, lots, timelines)

Item	Lenskart	Studds
Price band	₹382–₹402	₹557–₹585
Market lot	37 shares	25 shares
Min retail amount	~₹14,874 (at lower band)*	₹14,625
Issue structure	Fresh ₹2,150 cr + OFS (~12.76 cr shares)	100% OFS (~₹455.5 cr)
Bid window	Oct 31–Nov 4	Oct 30–Nov 3
Tentative listing	Nov 10	(Post-close; date per exchange schedule)

*Illustrative; lot/amount details per trackers; check final RHP/broker for exact. 

4) GMP vs Reality — reading the signal

1. Sentiment today: Lenskart shows higher GMP (~21%) vs Studds (~10–11.5%). This signals stronger near-term listing optimism for Lenskart right now.  
2. But… GMP moves daily and often cools by listing. Treat it as a momentum gauge, not intrinsic value.  
3. Analyst take (Mint roundup): While sectors differ, some analysts see better medium-term upside in Studds given valuations—even if Lenskart’s near-term GMP is stronger.  

5) 360° Analysis (easy English)

A) Business strength

• Lenskart: Big brand recall, tech-enabled retail, scale in India + international, and integrated supply chain can protect margins. Large, growing vision-care market supports multi-year growth.  
• Studds: Category leader in helmets; steady two-wheeler base in India, safety regulation tailwinds, multiple brands and price points; exports potential.  

B) Use of money (fresh vs OFS)

• Lenskart raises new money (fresh issue)—can fund expansion, stores, supply chain, tech. Positive for future growth.  
• Studds issue is pure OFS—company does not receive fresh funds; neutral for growth funding on listing day.  

C) Valuation temperature

• Lenskart: Large consumer-tech retail brand; valuation expectations are rich (upper band implies ~₹70k cr). High growth stories often list strong when sentiment is risk-on, but carry valuation risk if growth/margins miss.  
• Studds: Traditional manufacturing/brand play; GMP indicates modest listing pop but may offer reasonable medium-term risk-reward if execution and demand remain firm.  

D) Demand/Subscription trend

• Early full subscription Day-1 for Lenskart shows broad interest; anchor demand supports that narrative.  
• Studds saw anchors (~₹137 cr) and improving subscriptions into Day-2; sentiment steady with single-digit GMP to low-teens.  

E) Risks & what to watch

1. GMP volatility: A 10–20 point swing can change listing math quickly.  
2. Sector cyclicality:
   
• Lenskart—consumer spending, competitive intensity (offline optical chains, e-com), international execution.  
• Studds—two-wheeler sales cycle, price competition (other helmet brands), input costs.  
3. 
   
4. OFS heavy supply: Studds being 100% OFS adds supply without fresh growth capital; Lenskart has both fresh + OFS—watch free float and selling shareholders.  

6) Plain-English takeaways (who should consider what)

• Looking for potential listing pop: Lenskart currently shows stronger GMP (~21%), so near-term listing gain odds look better today—with the standard caveat that GMP can fall.  
• Looking for steadier, fundamentals-first story: Studds is a category leader with industrial cash-flow characteristics; analysts in Mint’s wrap hinted better medium-to-long-term potential at offered valuations, even if Day-1 pop is lower.  
• Risk control:
  
1. Do not apply purely on GMP.
2. Size your lot count so that a 5–10% adverse listing move won’t hurt your overall portfolio.
3. If in doubt, consider one lot for discovery and add only post-listing after results/updates.

7) References & further reading

• Mint: Side-by-side GMP and subscription context, updated Nov 1, 2025.  
• Lenskart—baseline IPO details/valuation: Reuters overview; Moneycontrol IPO page; IPOWatch dates/lot/fresh+OFS split.  
• Studds—price band, OFS, dates, anchors, GMP: ET/Business-Standard coverage; NDTV Profit GMP tracker.  
• Company/sector notes: Axis Capital investor education note (Lenskart); ICICI Direct note (Studds).  

8) Bottom line (one line each)

• Lenskart: Higher-growth retail brand with bigger fresh-issue muscle; higher GMP today, but rich expectations.  
• Studds: Market leader in helmets; modest GMP, cleaner manufacturing story; may suit patient investors.